0.5% Metronidazole USP by Qatar Pharma

0.5% Metronidazole USP by Qatar Pharma is a sterile, non-pyrogenic IV formulation containing 5 mg/mL of metronidazole. It is indicated for the treatment of anaerobic infections and protozoal diseases, including Giardia, Trichomonas, and Entamoeba species, as well as infections involving the gastrointestinal tract, reproductive organs, skin, and soft tissues. Packaged in a 100 mL vial, this ready-to-use solution ensures precise dosing, rapid action, and consistent results in both veterinary and clinical environments.

Usage:

Target Species: Dogs, cats, equines and livestock 

Indications:

• Anaerobic bacterial infections (e.g., peritonitis, abscesses, deep soft tissue infections)

• Protozoal infections (Giardiasis, Trichomoniasis)

• Infections of the gastrointestinal tract, reproductive organs, and oral cavity

• Pre- and post-operative prophylaxis in contaminated surgical procedures

Application: Intravenous infusion only; to be used under medical or veterinary supervision

Dosage: 7.5 mg/kg every 6–8 hours or as advised by a healthcare provider; infusion rate and duration to be tailored to species and clinical condition

Method: Administer via controlled IV infusion; avoid rapid bolus to minimize side effects. Shake well before use

Frequency: 2–3 times daily depending on severity and type of infection

Features and Benefits:

• 0.5% metronidazole (5 mg/mL): Broad-spectrum activity against anaerobes and protozoa

• Sterile 100 mL vial: Convenient size for clinical and field use

• Rapid onset of action: Delivers systemic therapeutic levels quickly

• Versatile anti-infective agent: Trusted for gastrointestinal, reproductive, and dental infections

• Veterinary- and human-grade: High safety and efficacy profile when used as directed